Circulating fibrinogen is a prognostic and predictive biomarker in malignant pleural mesothelioma

被引：0
|
作者：
B Ghanim
M A Hoda
T Klikovits
M-P Winter
A Alimohammadi
M Grusch
B Dome
M Arns
P Schenk
M Jakopovic
M Samarzija
L Brcic
M Filipits
V Laszlo
W Klepetko
W Berger
B Hegedus
机构：
[1] Medical University of Vienna,Division of Thoracic Surgery, Department of Surgery
[2] Institute of Cancer Research,Department of Internal Medicine I
[3] Medical University of Vienna,Department of Thoracic Surgery
[4] National Koranyi Institute of Pulmonology,Department of Pulmonology
[5] National Institute of Oncology,Department for Respiratory Diseases Jordanovac
[6] LKH Hochegg,Department of Biological Physics
[7] University of Zagreb,undefined
[8] School of Medicine,undefined
[9] University Hospital Center,undefined
[10] University of Zagreb,undefined
[11] School of Medicine,undefined
[12] Institute of Pathology,undefined
[13] Eötvös University,undefined
[14] MTA-SE Molecular Oncology Research Group,undefined
[15] Hungarian Academy of Sciences,undefined
来源：
British Journal of Cancer | 2014年 / 110卷
关键词：
malignant pleural mesothelioma; fibrinogen; prognosis; predictive biomarker; multimodality therapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：984 / 990
页数：6
相关论文
共 50 条
  • [31] Pleural effusion VEGF levels as a prognostic factor of malignant pleural mesothelioma
    Hirayama, Noriko
    Tabata, Chiharu
    Tabata, Rie
    Maeda, Risa
    Yasumitsu, Akihiro
    Yamada, Shusai
    Kuribayashi, Kozo
    Fukuoka, Kazuya
    Nakano, Takashi
    RESPIRATORY MEDICINE, 2011, 105 (01) : 137 - 142
  • [32] Pleural effusion hyaluronic acid as a prognostic marker in pleural malignant mesothelioma
    Creaney, Jenette
    Dick, Ian M.
    Segal, Amanda
    Musk, Arthur W.
    Robinson, Bruce W. S.
    LUNG CANCER, 2013, 82 (03) : 491 - 498
  • [33] Predictive and Prognostic Value of Clinical TNM Staging for Patients with Malignant Pleural Mesothelioma Undergoing Surgery
    Gill, Ritu R.
    Bueno, Raphael
    Richards, William
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S224 - S224
  • [34] Identification and validation of a prognostic signature in malignant pleural mesothelioma
    Zhou, J-G.
    Ma, H.
    ANNALS OF ONCOLOGY, 2018, 29
  • [35] Prognostic significance of osteopontin expression in malignant pleural mesothelioma
    Cappia, Susanna
    Righi, Luisella
    Ceppi, Paolo
    Volante, Marco
    Bacillo, Elisa
    Ardissone, Francesco
    Mirabelli, Dario
    Scagliotti, Giorgio V.
    Papotti, Mauro
    VIRCHOWS ARCHIV, 2007, 451 (02) : 431 - 431
  • [36] A NOVEL PROGNOSTIC MICRORNA SIGNATURE IN MALIGNANT PLEURAL MESOTHELIOMA
    Grossi, F.
    Truini, A.
    Nadal, E.
    Genova, C.
    Rijavec, E.
    Barletta, G.
    Biello, F.
    Beer, D. G.
    Coco, S.
    ANNALS OF ONCOLOGY, 2014, 25
  • [37] Molecular prognostic markers in Malignant Pleural Mesothelioma (MPM)
    Bahnassy, Abeer A.
    Gaafar, Rabab M.
    Zekri, Abdel-Rahman N.
    Abdelrahman, Abdelrahman M.
    Aboulkassem, Fatma A.
    Elsherif, Ghada M.
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S757 - S757
  • [38] Prognostic factors affecting survival in malignant pleural mesothelioma
    Komurcuoglu, Berna Eren
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [39] Increased Circulating miR-625-3p A Potential Biomarker for Patients With Malignant Pleural Mesothelioma
    Kirschner, Michaela B.
    Cheng, Yuen Yee
    Badrian, Bahareh
    Kao, Steven C.
    Creaney, Jenette
    Edelman, J. James B.
    Armstrong, Nicola J.
    Vallely, Michael P.
    Musk, Arthur W.
    Robinson, Bruce W. S.
    McCaughan, Brian C.
    Klebe, Sonja
    Mutsaers, Steven E.
    van Zandwijk, Nico
    Reid, Glen
    JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (07) : 1184 - 1191
  • [40] MicroRNA prognostic signature in malignant pleural mesothelioma.
    Grossi, Francesco
    Truini, Anna
    Nadal, Ernest
    Genova, Carlo
    Rijavec, Erika
    Barletta, Giulia
    Biello, Federica
    Coco, Simona
    Dal Bello, Maria Giovanna
    Vanni, Irene
    Alama, Angela
    Beer, David G.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
12345